Earnings Call Intelligence Subscribe
13F holdings

DME Capital Management (Greenlight Capital)

David Einhorn's value book. Concentrated, contrarian, and famously willing to be early; the long book is only one side of what he runs.
Q2 2026 13F-HR, reported as of 2026-06-30 and filed 2026-08-14 · CIK 1489933 · filings on EDGAR
$3.91B
reported book
46
equity positions
53%
in the top 10
10 of 46
names we cover
Private client access

The forensic read on this book

Anyone can read a 13F. The question is whether the management teams inside it do what they say. We track every forward-looking promise made on these companies' earnings calls and score whether it was kept - 10 of the 46 names here, 33% of the book by value.

Open the analysis →
Password required. Request access at zack@callsheetdaily.com.

Every position, Q2 2026

All 46 equity positions reported on the 2026-06-30 13F, largest first.

#TickerIssuer% of bookValueSharesvs Q1 2026
1GRBKGreen Brick Partners Inc19.39%$757.8M9,467,383Unchanged
2FLRFluor Corp6.24%$244.1M4,658,750Trimmed
-2%
3CNRCore Natural Resources Inc4.67%$182.7M2,283,200Added
+23%
4BHFBrighthouse Finl Inc4.60%$179.9M2,842,100Unchanged
5ACHCAcadia Healthcare Company In3.32%$130.0M4,400,641Trimmed
-3%
6PENNPenn Entertainment Inc3.20%$125.2M5,860,270Trimmed
-3%
7FBINFortune Brands Innovations I3.15%$123.1M2,241,875New
8PCGPg&Amp;E Corp2.85%$111.6M6,632,852Unchanged
9CNCCentene Corp Del2.71%$106.0M1,651,150Trimmed
-40%
10GPKGraphic Packaging Hldg Co2.69%$105.2M9,953,430Added
+9%
11SNXTd Synnex Corporation2.61%$101.9M381,042Trimmed
-21%
12TEVATeva Pharmaceutical Inds Ltd2.50%$97.8M2,886,059Unchanged
13VGNTVersigent Plc2.45%$95.7M2,277,640New
14CPRICapri Holdings Limited2.29%$89.5M4,820,118Trimmed
-2%
15BKVBkv Corp2.17%$84.7M3,095,173Added
+15%
16DHTDht Holdings Inc2.13%$83.2M5,034,320Trimmed
-5%
17CROXCrocs Inc2.07%$80.7M669,140Unchanged
18ROIVRoivant Sciences Ltd1.95%$76.2M2,152,669Unchanged
19SHCSotera Health Co1.88%$73.4M4,135,515Added
+100%
20VSNTVersant Media Group Inc1.77%$69.2M1,922,172Trimmed
-37%
21PRMBPrimo Brands Corporation1.77%$69.0M2,823,660New
22DCHDauch Corp1.72%$67.2M12,395,104Added
+96%
23PYPLPaypal Hldgs Inc1.57%$61.5M1,424,320New
24HSICSchein Henry Inc1.54%$60.0M718,550Added
+20%
25WBDWarner Bros Discovery Inc1.53%$59.9M2,246,180New
26LBTYALiberty Global Ltd1.44%$56.4M4,963,322Unchanged
27ARAntero Resources Corp1.42%$55.3M1,574,140Added
+95%
28STUBStubhub Hldgs Inc1.39%$54.5M4,233,200Unchanged
29REZIResideo Technologies Inc1.35%$52.9M1,699,590Added
+8%
30DECKDeckers Outdoor Corp1.29%$50.3M506,398Added
+5%
31SPBSpectrum Brands Holdings Inc1.23%$48.1M561,438Trimmed
-14%
32CNHCnh Indl N V1.20%$47.0M4,188,940Unchanged
33VTRSViatris Inc1.13%$44.0M2,773,470Added
+53%
34PSKYParamount Skydance Corp0.99%$38.7M3,926,080Unchanged
35PVHPvh Corporation0.99%$38.7M520,800New
36CMCSAComcast Corp New0.85%$33.0M1,345,780New
37SLDESlide Ins Hldgs Inc0.84%$32.7M1,686,630Unchanged
38TRIPTripadvisor Inc0.83%$32.4M2,361,973Added
+51%
39GLDSpdr Gold Tr0.79%$30.7M83,421Trimmed
-16%
40CIThe Cigna Group0.62%$24.4M88,400Unchanged
41LKFTLakefront Biotherapeutics Nv0.37%$14.5M482,746Unchanged
42COYACoya Therapeutics Inc0.35%$13.7M2,335,540Unchanged
43IMVTImmunovant Inc0.09%$3.6M93,520Unchanged
44GPROGopro Inc0.03%$1.3M1,693,860Unchanged
45GANXGain Therapeutics Inc0.03%$1.1M566,130Unchanged
46NUVBNuvation Bio Inc<0.01%$198,77234,995Unchanged
Ticker links go to that company's management-credibility page. Share counts are adjusted for stock splits where a split occurred between the two reporting dates; the adjustment is noted on the row.

Bought in Q2 2026

Positions that did not appear on the prior quarter's 13F.

TickerIssuer% of bookValueShares
FBINFortune Brands Innovations I3.15%$123.1M2,241,875
VGNTVersigent Plc2.45%$95.7M2,277,640
PRMBPrimo Brands Corporation1.77%$69.0M2,823,660
PYPLPaypal Hldgs Inc1.57%$61.5M1,424,320
WBDWarner Bros Discovery Inc1.53%$59.9M2,246,180
PVHPvh Corporation0.99%$38.7M520,800
CMCSAComcast Corp New0.85%$33.0M1,345,780

Sold out in Q2 2026

Positions on the Q1 2026 13F that are gone from this one. Value shown is what the position was worth at the prior reporting date.

TickerIssuerValue at prior quarterShares held
VSXYVictorias Secret And Co$104.6M2,256,889
SLMSlm Corp$45.0M2,101,840
PTONPeloton Interactive Inc$43.4M10,113,940
WFRDWeatherford Intl Plc$13.8M145,721
ZIMZim Integrated Shipping Serv$9.3M354,526
-Katapult Holdings Inc$603262,227

Book history

Reported 13F value and position count by quarter.

QuarterReportedBook valuePositions
Q2 20262026-06-30$3.91B46
Q1 20262026-03-31$3.19B45
Q4 20252025-12-31$2.85B41
Q3 20252025-09-30$2.54B37
Q2 20252025-06-30$2.33B34
Q1 20252025-03-31$1.97B33
Q4 20242024-12-31$1.94B36
Q3 20242024-09-30$2.40B38
Q2 20242024-06-30$2.04B39
Q1 20242024-03-31$2.18B42

How this page is built

Positions come straight from the fund's Form 13F-HR information table on SEC EDGAR, with amendments applied in filing order (a restatement replaces the table, a new-holdings amendment adds to it). Securities are identified by CUSIP rather than by issuer name, because name matching is how a book ends up showing an obscure over-the-counter line instead of the mega-cap it actually holds. Reported values are normalized to whole dollars across the 2023 change in the 13F value units.

A 13F is a quarterly snapshot of long US-listed equity positions, filed up to 45 days after the quarter ends. It does not show short positions, cash, debt, private holdings, or non-US listings, and the book will have moved since the reporting date. Read it as a record of what was held on 2026-06-30, not as a current portfolio.

Holdings data is from public SEC Form 13F-HR filings and is reproduced here as filed. A 13F reports long US-listed equity positions only, as of the quarter-end reporting date.
Scores, kept-promise rates, and flags on this site reflect the author's opinion, applying a stated methodology to statements management made on public earnings calls. Informational and educational purposes only - not investment advice, a recommendation, or an offer to buy or sell any security. Sources believed reliable but not guaranteed; the author may hold positions in the securities discussed.